NDUFS4 and inborn mitochondrial metabolism disorder: The effect of rapamycin has been tested in NDUFS4 KO mice, with results from this and other studies showing that mTORC1 inhibition alleviated mitochondrial disease in the mouse model of LS (Johnson et al., 2013; Cheema et al., 2021).